USE OF TWO BLOOD-BASED BIOMARKER TESTS IN SERIES TO RECLASSIFY RISK OF INDETERMINATE PULMONARY NODULES

被引：0
|
作者：
Pitcher, Trevor
Jett, James
Springmeyer, Steven
Doubleday, Kevin
Peek, Laura
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1331
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1476A / 1477A
页数：2
相关论文
共 50 条
  • [21] RACIAL COMPARISONS OF RECEPTIVITY TO A BLOOD-BASED BIOMARKER TEST FOR ALZHEIMER RISK
    Skemp, Eleanor
    Cho, Hyun Jin
    Carpenter, Brian
    INNOVATION IN AGING, 2023, 7 : 1104 - 1105
  • [22] Assessing the risk of TB progression: Advances in blood-based biomarker research
    Li, Zhaodong
    Hu, Yunlong
    Zou, Fa
    Gao, Wei
    Feng, Siwan
    Chen, Guanghuan
    Yang, Jing
    Wang, Wenfei
    Shi, Chenyan
    Cai, Yi
    Deng, Guofang
    Chen, Xinchun
    MICROBIOLOGICAL RESEARCH, 2025, 292
  • [23] Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment
    Fahrmann, Johannes F.
    Marsh, Tracey
    Irajizad, Ehsan
    Patel, Nikul
    Murage, Eunice
    Vykoukal, Jody
    Dennison, Jennifer B.
    Do, Kim-Anh
    Ostrin, Edwin
    Spitz, Margaret R.
    Lam, Stephen
    Shete, Sanjay
    Meza, Rafael
    Tammemagi, Martin C.
    Feng, Ziding
    Hanash, Samir M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (08) : 876 - +
  • [24] Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules
    Charles E. Birse
    Jennifer L. Tomic
    Harvey I. Pass
    William N. Rom
    Robert J. Lagier
    Clinical Proteomics, 2017, 14
  • [25] Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules
    Birse, Charles E.
    Tomic, Jennifer L.
    Pass, Harvey I.
    Rom, William N.
    Lagier, Robert J.
    CLINICAL PROTEOMICS, 2017, 14
  • [26] First Look at the Distribution of Risk of Malignancy Pre and Post-Test Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study
    Pritchett, M.
    Sigal, B. W.
    Bowling, M. R.
    Morganroth, M. L.
    Bernstein, M. A.
    Shah, A.
    Seaman, J.
    Gordon, J.
    Nakahodo, A. Aragaki
    Romero, A. O.
    Kurman, J. S.
    Berry, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Current advances and future prospects of blood-based techniques for identifying benign and malignant pulmonary nodules
    Wang, Xin
    Chen, Yanmei
    Ma, Chengcheng
    Bi, Lingfeng
    Su, Zhixi
    Li, Weimin
    Wang, Zhoufeng
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 207
  • [28] The Performance of Two Commercial, Diagnostic Blood Tests to Evaluate the Incidentally Detected, Indeterminate Pulmonary Nodule
    Lin, Gary
    Tripathi, Pragya
    Naemi, Harris
    Nair, Viswam
    CHEST, 2016, 150 (04) : 733A - 733A
  • [29] The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules
    Shahram Tahvilian
    Joshua D. Kuban
    David F. Yankelevitz
    Daniel Leventon
    Claudia I. Henschke
    Jeffrey Zhu
    Lara Baden
    Rowena Yip
    Fred R. Hirsch
    Rebecca Reed
    Ashley Brown
    Allison Muldoon
    Michael Trejo
    Benjamin A. Katchman
    Michael J. Donovan
    Paul C. Pagano
    BMC Pulmonary Medicine, 23
  • [30] No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease
    Chiam, Justin Tao Wen
    Lunnon, Katie
    Voyle, Nicola
    Proitsi, Petroula
    Coppola, Giovanni
    Geschwind, Daniel
    Nelson, Sally
    Johnston, Caroline
    Soininen, Hilkka
    Kloszewska, Iwona
    Mecocci, Patrizia
    Tsolaki, Magda
    Vellas, Bruno
    Hodges, Angela
    Lovestone, Simon
    Newhouse, Stephen
    Dobson, Richard James Butler
    Kiddle, Steven John
    Sattlecker, Martina
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (03) : 741 - 750
12345